Literature DB >> 19683522

Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.

Vaclav Vaja1, Peter Ochodnicky, Peter Krenek, Jan Klimas, Zuzana Bajuszova, Jan Kyselovic.   

Abstract

Chronic treatment with several antihypertensive agents, including calcium channel blockers, may interfere with remodeling of large arteries and increased arterial stiffness. We hypothesize that even a short, seven-day administration of calcium channel blockers might alter an aortic remodeling in spontaneously hypertensive rat (SHR). Male SHR and normotensive WKY rats (n=14 each) were treated by either vehicle, vasculoselective calcium channel blocker nifedipine (1mg/kg/day) or cardiac/vascular calcium channel blockers diltiazem (5mg/kg/day) or verapamil (4 mg/kg/day, n=6 for each treatment) subcutaneously twice daily for seven days. Additional SHR rats were randomized for termination 24, 72 or 120 h (n=5 each) after the withdrawal of nifedipine. Systolic blood pressure was measured by tail cuff and thoracic aorta was collected for histomorphometric and functional analysis including acetylcholine-induced endothelium-dependent relaxation. Seven-day administration of diltiazem and nifedipine, but not verapamil decreased blood pressure in SHR. All drugs significantly attenuated abnormal aortic wall thickness, cross-sectional area and media-to-lumen ratio, but only nifedipine improved impaired endothelium-dependent relaxation. Following the withdrawal of nifedipine, all measured parameters returned back to control SHR values within 72 h. Seven-day treatment with distinct calcium channel blockers attenuates hypertensive remodeling of aorta, which might be, in case of nifedipine, reactivated even by a very short withdrawal of the drug. Therefore, vasculoprotection by calcium channel blockers is not restricted to a prolonged blood pressure modulation, but occurs rapidly. These findings could be relevant for an intervention in augmented vascular stiffness and related cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683522     DOI: 10.1016/j.ejphar.2009.08.003

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Early intervention of long-acting nifedipine GITS reduces brachial-ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.

Authors:  Jidong Zhang; Yan Wang; Haijuan Hu; Xiaohong Yang; Zejun Tian; Demin Liu; Guoqiang Gu; Hongmei Zheng; Ruiqin Xie; Wei Cui
Journal:  Drug Des Devel Ther       Date:  2016-10-18       Impact factor: 4.162

2.  Anti-Hypertensive Effects of Acacia Polyphenol in Spontaneously Hypertensive Rats.

Authors:  Nobutomo Ikarashi; Takahiro Toda; Yusuke Hatakeyama; Yoshiki Kusunoki; Risako Kon; Nanaho Mizukami; Miho Kaneko; Sosuke Ogawa; Kiyoshi Sugiyama
Journal:  Int J Mol Sci       Date:  2018-03-01       Impact factor: 5.923

3.  The protective effect of dronedarone on the structure and mechanical properties of the aorta in hypertensive rats by decreasing the concentration of symmetric dimethylarginine (SDMA).

Authors:  Begoña Quintana-Villamandos; María Del Carmen González; María Jesús Delgado-Martos; Perla Yareli Gutiérrez-Arzapalo; Rainer H Böger; Nicole Lüneburg; David Muñoz; Emilio Delgado-Baeza
Journal:  PLoS One       Date:  2019-05-21       Impact factor: 3.240

4.  LC-MS analysis of Myrica rubra extract and its hypotensive effects via the inhibition of GLUT 1 and activation of the NO/Akt/eNOS signaling pathway.

Authors:  Jing Li; Huiling Wang; Jian Li; Yonggang Liu; Hong Ding
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

5.  Herbicidal properties of antihypertensive drugs: calcium channel blockers.

Authors:  Hannan Safiyyah Tan Sian Hui Abdullah; Poh Wai Chia; Dzolkhifli Omar; Tse Seng Chuah
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

6.  Loss of HtrA1 serine protease induces synthetic modulation of aortic vascular smooth muscle cells.

Authors:  Muthi Ikawati; Masashi Kawaichi; Chio Oka
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.